Selective use of vandetanib in the treatment of thyroid cancer.
about
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibitionEfficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis.
P2860
Selective use of vandetanib in the treatment of thyroid cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective use of vandetanib in the treatment of thyroid cancer.
@en
type
label
Selective use of vandetanib in the treatment of thyroid cancer.
@en
prefLabel
Selective use of vandetanib in the treatment of thyroid cancer.
@en
P2093
P2860
P921
P356
P1476
Selective use of vandetanib in the treatment of thyroid cancer.
@en
P2093
Alessandro Antonelli
Flavia Di Bari
Gabriele Materazzi
Paolo Miccoli
Poupak Fallahi
Roberto Spisni
Salvatore Benvenga
Silvia Martina Ferrari
P2860
P304
P356
10.2147/DDDT.S72495
P407
P5008
P577
2015-07-03T00:00:00Z